Novartis AG (NVS) stock forecast for 2026. Forecast tables and graphs.

Novartis AG (NVS) stock forecast for 2026

The forecast has been updated: September 15, 2021 14:05


Novartis AG stock price online today

Analyst Target Price

103.33

Dividend Date

15.03.2021

Ex Dividend Date

04.03.2021

Last Split Factor

1116:1000

Last Split Date

09.04.2019

Should you buy or sell Novartis AG stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Novartis AG stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $103.33 target price for Novartis AG stock stock.

Today 200 Day Moving Average is the support level (89.44 $).

50 Day Moving Average is the resistance level (91.64 $).




NVS Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 81.97 80.46 84.04 4.25 %
Feb 82.86 81.13 85.08 4.64 %
Mar 82.10 80.85 84.56 4.39 %
Apr 80.98 79.23 83.51 5.12 %
May 79.55 77.23 80.29 3.81 %
Jun 80.45 79.09 82.63 4.28 %
Jul 80.77 79.67 83.32 4.38 %
Aug 83.32 82.15 85.42 3.82 %
Sep 82.25 80.57 83.21 3.16 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novartis AG stock.


Novartis AG overview

Novartis AG Address

LICHTSTRASSE 35, BASEL, SWITZERLAND

Market Capitalization

210 292 800 000 $

EBITDA

19 062 999 000

PE Ratio

19.35

PEG Ratio

2.263

Dividend Per Share

3.4

Dividend Yield

0.0399

EPS

3.958

Quarterly Earnings Growth YOY

0.58

Quarterly Revenue Growth YOY

0.144

Trailing PE

21.61

Forward PE

12.53

EV To Revenue

4.305

EV To EBITDA

12.17

52 Week High

95.17

52 Week Low

74.07

50 Day Moving Average

91.64

200 Day Moving Average

89.44

Shares Outstanding

2236740000

Shares Float

2091329000

Shares Short Prior Month

4604600

Short Ratio

2.46

Percent Insiders

0.008

Percent Institutions

9.92

Novartis AG stock forecast for this year


Novartis AG stock forecast for Jan 2026.
Estimated Average Forecasted Novartis AG Price: 81.97. Negative monthly dynamics of the instrument is expected with 4.253% volatility is expected.

Pessimistic forecast: 80.46

Optimistic: 84.04


Novartis AG stock forecast for Feb 2026.
Estimated Average Forecasted Novartis AG Price: 82.86. Positive monthly dynamics of the instrument is expected with 4.636% volatility is expected.

Pessimistic forecast: 81.13

Optimistic: 85.08


Novartis AG stock forecast for Mar 2026.
Estimated Average Forecasted Novartis AG Price: 82.10. Negative monthly dynamics of the instrument is expected with 4.388% volatility is expected.

Pessimistic forecast: 80.85

Optimistic: 84.56


Novartis AG stock forecast for Apr 2026.
Estimated Average Forecasted Novartis AG Price: 80.98. Negative monthly dynamics of the instrument is expected with 5.120% volatility is expected.

Pessimistic forecast: 79.23

Optimistic: 83.51


Novartis AG stock forecast for May 2026.
Estimated Average Forecasted Novartis AG Price: 79.55. Negative monthly dynamics of the instrument is expected with 3.805% volatility is expected.

Pessimistic forecast: 77.23

Optimistic: 80.29


Novartis AG stock forecast for Jun 2026.
Estimated Average Forecasted Novartis AG Price: 80.45. Positive monthly dynamics of the instrument is expected with 4.283% volatility is expected.

Pessimistic forecast: 79.09

Optimistic: 82.63


Novartis AG stock forecast for Jul 2026.
Estimated Average Forecasted Novartis AG Price: 80.77. Positive monthly dynamics of the instrument is expected with 4.382% volatility is expected.

Pessimistic forecast: 79.67

Optimistic: 83.32


Novartis AG stock forecast for Aug 2026.
Estimated Average Forecasted Novartis AG Price: 83.32. Positive monthly dynamics of the instrument is expected with 3.824% volatility is expected.

Pessimistic forecast: 82.15

Optimistic: 85.42


Novartis AG stock forecast for Sep 2026.
Estimated Average Forecasted Novartis AG Price: 82.25. Negative monthly dynamics of the instrument is expected with 3.163% volatility is expected.

Pessimistic forecast: 80.57

Optimistic: 83.21



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.44 (16.09.2021) -0.04 %
AbbVie Inc.
ABBV 108.08 (16.09.2021) 0.29 %
Aeterna Zentaris Inc.
AEZS 0.6143 (16.09.2021) -0.73 %
Allakos Inc.
ALLK 105.77 (16.09.2021) -2.27 %
Allogene Therapeutics, Inc.
ALLO 24.51 (16.09.2021) -1.96 %
Amgen Inc.
AMGN 217.36 (16.09.2021) -0.35 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.87 (16.09.2021) -0.19 %
Aurora Cannabis Inc.
ACB 6.62 (16.09.2021) -0.90 %
Becton Dickinson and Company
BDX 262.67 (16.09.2021) 0.38 %
Biogen Inc.
BIIB 299.69 (16.09.2021) 0.16 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 136.93 (16.09.2021) 0.69 %
BioNTech SE
BNTX 372.65 (16.09.2021) 4.90 %
bluebird bio, Inc.
BLUE 17.68 (16.09.2021) -0.67 %
Boston Scientific Corp.
BSX 44.9 (16.09.2021) -0.24 %
Bristol-Myers Squibb Company
BMY 61.23 (16.09.2021) -1.24 %
Canopy Growth Corp.
CGC 14.83 (16.09.2021) 0.27 %
Castle Biosciences, Inc.
CSTL 76.21 (16.09.2021) 1.99 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.14 (16.09.2021) -0.37 %
Eli Lilly and Company
LLY 231.04 (16.09.2021) -1.15 %
Emergent BioSolutions Inc.
EBS 57.47 (16.09.2021) 0.56 %
Exelixis, Inc.
EXEL 20.54 (16.09.2021) 0.34 %
G1 Therapeutics, Inc.
GTHX 14.27 (16.09.2021) 2.37 %
Gilead Sciences, Inc.
GILD 71.33 (16.09.2021) -0.60 %
GlaxoSmithKline plc
GSK 39.11 (16.09.2021) -0.28 %
GoodRx Holdings, Inc.
GDRX 45.93 (16.09.2021) 3.70 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.04 (16.09.2021) 2.18 %
Inovio Pharmaceuticals, Inc.
INO 7.75 (16.09.2021) 2.38 %
Johnson & Johnson
JNJ 165.22 (16.09.2021) -0.12 %
Medtronic plc.
MDT 130.92 (16.09.2021) -0.55 %
Merck & Co., Inc.
MRK 71.97 (16.09.2021) -1.15 %
Moderna, Inc.
MRNA 440.65 (16.09.2021) 1.42 %
Novartis AG
NVS 84.38 (16.09.2021) -0.82 %
Novavax, Inc.
NVAX 237.27 (16.09.2021) 2.14 %
ObsEva SA
OBSV 3.08 (16.09.2021) 0.65 %
OrganiGram Holdings Inc.
OGI 2.4 (16.09.2021) -0.83 %
Pfizer Inc.
PFE 44.47 (16.09.2021) -0.67 %
Regeneron Pharmaceuticals, Inc.
REGN 653.18 (16.09.2021) 0.18 %
Sanofi
SNY 48.19 (16.09.2021) 0.37 %
Schrodinger, Inc.
SDGR 61.15 (16.09.2021) 0.30 %
Senseonics Holdings, Inc.
SENS 3.82 (16.09.2021) -1.29 %
Sorrento Therapeutics, Inc.
SRNE 8.08 (16.09.2021) 1.76 %
Stryker Corp.
SYK 276.11 (16.09.2021) -0.36 %
Sundial Growers Inc.
SNDL 0.7193 (16.09.2021) -1.44 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (16.09.2021) -0.22 %
Thermo Fisher Scientific Inc.
TMO 560.44 (16.09.2021) -0.45 %
Tilray, Inc.
TLRY 12.01 (16.09.2021) -0.17 %
UnitedHealth Group, Inc.
UNH 416.84 (16.09.2021) -0.16 %
Veeva Systems Inc.
VEEV 305 (16.09.2021) 1.75 %
Zomedica Corp.
ZOM 0.5393 (16.09.2021) 1.56 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.32 (16.09.2021) -0.69 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.